Following the company’s second quarter results, Echelon Capital Markets analyst Stefan Quennev... Read More
Following the company’s fourth quarter results, Echelon Capital Markets analyst Stefan Quennev... Read More
With a new CFO and cost-cutting measures now in place, Echelon analyst Stefan Queneeville thinks the... Read More
New quarterly earnings from Valeo Pharma (Valeo Pharma Stock Quote, Charts, News, Analysts, Financia... Read More
Solid top and bottom line growth are the right prescription for Valeo Pharma (Valeo Pharma Stock Quo... Read More
Investors should be on the lookout for a turnaround in Valeo Pharma (Valeo Pharma Stock Quote, Chart... Read More
Echelon Capital Markets analyst Stefan Quenneville continues to like Valeo Pharma (Valeo Pharma Stoc... Read More
Investors should be gearing up for some movement in the biotech space, says iA Capital Markets analy... Read More
$0.50 to $0.70 per share — that’s been the range over the past 12 months for Canadian specialty ... Read More
Investors looking for growth-oriented stocks in the Canadian pharmaceutical space should be thinking... Read More
Research Capital Corp analyst André Uddin likes the new move by Canadian specialty pharma company V... Read More
The Healthcare space has taken it on the chin this year, as stocks across the board are down by well... Read More
Despite a target drop, Chelsea Stellick of iA Capital Markets isn’t panicking about Valeo Pharma I... Read More
It’s been an uncomfortable stretch for fans of Healthcare stocks, with names across the board losi... Read More
Research Capital Corporation analyst André Uddin is holding onto his value perception of Valeo Phar... Read More
There’s still good long-term growth prospects to the name but Research Capital Corporation ana... Read More
Paradigm Capital analyst Scott McAuley makes the case for investing in Canadian pharmaceutical compa... Read More
Valeo Pharma (Valeo Pharma Stock Quote, Chart, News, Analysts, Financials CSE:VPH) is poised to do ... Read More
Share
Tweet
pin
Share